Q2 2026 13F · SEC CIK 1910321
Troluce Capital Advisors LLC
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $267.0M
- Reported positions
- 12
- Top holdings a year, 3 yrs
- +27.1%
- Assets under management
- $2.2B
Troluce Capital Advisors LLC is a hedge fund that reported 12 positions worth $267.0M in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Amentum Holdings Inc (AMTM, 27.6%), EchoStar Corp (ECHO, 20.7%), Mineralys Therapeutics Inc (MLYS, 17.5%). A portfolio copying its top holdings returned 27.1% a year over the last 3 years, against 20.4% for the S&P 500.
Troluce Capital Advisors LLC holdings all 12 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| AMTMAmentum Holdings Inc | 27.6% | +256.5% | $73.7M |
| ECHOEchoStar Corp | 20.7% | -9.4% | $55.2M |
| MLYSMineralys Therapeutics Inc | 17.5% | +163.9% | $46.6M |
| MIRMirion Technologies Inc | 10.3% | +2.6% | $27.6M |
| AEISAdvanced Energy Inds Inc | 9.1% | — | $24.2M |
| STOKStoke Therapeutics Inc | 6.1% | -24.0% | $16.2M |
| GDGeneral Dynamics Corp | 3.6% | — | $9.7M |
| QQnity Electronics Inc Common Stock | 1.8% | — | $4.9M |
| HONHoneywell Intl Inc | 1.4% | — | $3.7M |
| QXOQxo Inc | 1.3% | — | $3.5M |
| INIOInnio NV | 0.6% | — | $1.5M |
| ABVXAbivax SA | 0.1% | — | $133K |
What Troluce Capital Advisors LLC bought and sold in Q2 2026, against Q1 2026.
New positions
- AEIS Advanced Energy Inds Inc9.1% of 13F
- GD General Dynamics Corp3.6% of 13F
- Q Qnity Electronics Inc Common Stock1.8% of 13F
- HON Honeywell Intl Inc1.4% of 13F
- QXO Qxo Inc1.3% of 13F
- INIO Innio NV0.6% of 13F
- ABVX Abivax SA0.1% of 13F
Added to
- AMTM Amentum Holdings Inc+256.5% shares
- MLYS Mineralys Therapeutics Inc+163.9% shares
Reduced
- STOK Stoke Therapeutics Inc-24.0% shares
- ECHO EchoStar Corp-9.4% shares
Sold out
- BATRK Atlanta Braves Hldgs Incwas 9.2%
- COF Capital One Finl Corpwas 6.0%
- FWONK Liberty Media Corp Delwas 5.9%
- LYV Live Nation Entertainment inwas 5.4%
- FTAI Ftai Aviation Ltdwas 4.1%
- WULF Terawulf Incwas 3.6%
- APTV Aptiv PLCwas 3.3%
- DY Dycom Inds Incwas 3.3%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +30.0% /yr
- S&P 500 +20.1%
- 3 years
- +27.1% /yr
- S&P 500 +20.4%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $267.0M | 12 |
| Q1 2026 | $923.8M | 45 |
| Q4 2025 | $129.3M | 9 |
| Q3 2025 | $282.2M | 21 |
| Q2 2025 | $196.4M | 18 |
| Q1 2025 | $106.0M | 16 |
| Q4 2024 | $992.9M | 16 |
| Q3 2024 | $559.7M | 44 |
| Q2 2024 | $476.9M | 35 |
| Q1 2024 | $450.1M | 45 |
| Q4 2023 | $221.9M | 17 |
| Q3 2023 | $164.1M | 24 |
Questions about Troluce Capital Advisors LLC's portfolio
What stocks does Troluce Capital Advisors LLC own?
Troluce Capital Advisors LLC's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 12 positions worth $267.0M. The largest are Amentum Holdings Inc (AMTM) at 27.6%, EchoStar Corp (ECHO) at 20.7%, Mineralys Therapeutics Inc (MLYS) at 17.5%, Mirion Technologies Inc (MIR) at 10.3% and Advanced Energy Inds Inc (AEIS) at 9.1%.
What did Troluce Capital Advisors LLC buy last quarter?
In Q2 2026, Troluce Capital Advisors LLC added a new position in Advanced Energy Inds Inc (AEIS), a new position in General Dynamics Corp (GD), a new position in Qnity Electronics Inc Common Stock (Q), a new position in Honeywell Intl Inc (HON), a new position in Qxo Inc (QXO), Amentum Holdings Inc (AMTM) (+256.5% shares) and Mineralys Therapeutics Inc (MLYS) (+163.9% shares), compared with its Q1 2026 filing.
What did Troluce Capital Advisors LLC sell last quarter?
In Q2 2026, Troluce Capital Advisors LLC sold all of Atlanta Braves Hldgs Inc (BATRK), sold all of Capital One Finl Corp (COF), sold all of Liberty Media Corp Del (FWONK), sold all of Live Nation Entertainment in (LYV), sold all of Ftai Aviation Ltd (FTAI), Stoke Therapeutics Inc (STOK) (-24.0% shares) and EchoStar Corp (ECHO) (-9.4% shares), compared with its Q1 2026 filing.
How has Troluce Capital Advisors LLC's portfolio performed?
A portfolio copying Troluce Capital Advisors LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +27.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +30.0% against +20.1%.
When is Troluce Capital Advisors LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Troluce Capital Advisors LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Troluce Capital Advisors LLC manage?
Troluce Capital Advisors LLC reported $2.2B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $267.0M.